Hedge Fund - Rhenman & Partners Asset Management
Elevance Health Inc. (ELV)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $21,291,292 | 2.45% | 48,950 | $401.43 |
| 2 | 2024 - Q4 (2024-12-31) | $8,540,035 | 0.87% | 23,150 | $418.46 |
| 3 | 2024 - Q3 (2024-09-30) | $26,260,000 | 2.13% | 50,500 | $534.22 |
| 4 | 2024 - Q2 (2024-06-30) | $46,491,588 | 4.46% | 85,800 | $528.58 |
| 5 | 2024 - Q1 (2024-03-31) | $36,038,530 | 3.41% | 69,500 | $497.33 |
| 6 | 2023 - Q4 (2023-12-31) | $6,130,280 | 0.61% | 13,000 | $462.41 |
| 7 | 2023 - Q3 (2023-09-30) | $16,545,960 | 1.78% | 38,000 | $453.58 |
| 8 | 2023 - Q2 (2023-06-30) | $24,880,240 | 2.62% | 56,000 | $461.32 |
| 9 | 2023 - Q1 (2023-03-31) | $25,699,520 | 2.82% | 56,000 | $475.89 |
| 10 | 2022 - Q4 (2022-12-31) | $23,083,650 | 2.4% | 45,000 | $507.74 |
| 11 | 2022 - Q3 (2022-09-30) | $21,871,000 | 2.29% | 40,000 | $478.49 |
| 12 | 2022 - Q2 (2022-06-30) | $27,507,000 | 3.12% | 57,000 | $494.71 |
| 13 | 2022 - Q1 (2022-03-31) | $22,694,000 | 2.23% | 46,199 | $457.10 |
| 14 | 2021 - Q4 (2021-12-31) | $45,781,000 | 3.04% | 98,000 | $420.70 |
| 15 | 2021 - Q3 (2021-09-30) | $44,736,000 | 3.13% | 120,000 | $380.04 |
| 16 | 2021 - Q2 (2021-06-30) | $36,271,000 | 2.46% | 95,000 | $382.16 |
| 17 | 2021 - Q1 (2021-03-31) | $34,100,000 | 2.37% | 95,000 | $321.58 |
| 18 | 2020 - Q4 (2020-12-31) | $25,687,000 | 2.09% | 80,000 | $306.88 |
| 19 | 2020 - Q3 (2020-09-30) | $24,173,000 | 2.14% | 90,000 | $269.07 |
| 20 | 2020 - Q2 (2020-06-30) | $17,094,000 | 1.84% | 65,000 | $266.78 |
| 21 | 2020 - Q1 (2020-03-31) | $14,758,000 | 2.06% | 65,000 | $272.52 |
| 22 | 2019 - Q4 (2019-12-31) | $18,726,000 | 2.05% | 62,000 | $275.19 |
| 23 | 2019 - Q3 (2019-09-30) | $14,406,000 | 1.8% | 60,000 | $273.99 |
| 24 | 2019 - Q2 (2019-06-30) | $25,399,000 | 2.79% | 90,000 | $273.16 |
| 25 | 2018 - Q4 (2018-12-31) | $20,655,000 | 2.36% | 78,645 | $274.98 |
| 26 | 2018 - Q3 (2018-09-30) | $19,184,000 | 1.92% | 70,000 | $259.59 |
| 27 | 2018 - Q2 (2018-06-30) | $18,090,000 | 1.85% | 76,000 | $231.57 |
| 28 | 2018 - Q1 (2018-03-31) | $13,402,000 | 1.65% | 61,000 | $234.91 |
| 29 | 2017 - Q4 (2017-12-31) | $6,975,000 | 0.94% | 31,000 | $212.98 |
| 30 | 2017 - Q3 (2017-09-30) | $10,443,000 | 1.33% | 55,000 | $190.32 |
| 31 | 2017 - Q2 (2017-06-30) | $4,979,000 | 0.71% | 26,468 | $179.68 |
| 32 | 2017 - Q1 (2017-03-31) | $6,196,000 | 0.98% | 37,468 | $159.07 |
| 33 | 2016 - Q4 (2016-12-31) | $8,376,000 | 1.6% | 58,257 | $133.90 |
| 34 | 2016 - Q3 (2016-09-30) | $8,450,155,000 | 1.34% | 67,434 | $129.12 |
| 35 | 2016 - Q2 (2016-06-30) | $5,254,000 | 0.93% | 40,000 | $136.83 |
| 36 | 2016 - Q1 (2016-03-31) | $6,533,000 | 1.29% | 47,000 | $133.63 |
| 37 | 2015 - Q4 (2015-12-31) | $12,271,000 | 1.85% | 88,000 | $137.76 |
The displayed share prices are average quarterly stock market prices.